Omeros (OMER) Return on Sales (2010 - 2026)
Omeros (OMER) reported Return on Sales of 0.0% for Q1 2026, up 1.0% on a YoY basis from 0.0% in Q1 2025, and up 231.32% sequentially from 0.0% in Q1 2025.
Omeros (OMER) Return on Sales (2010 - 2026) Analysis & Trends
Omeros (OMER) has 15 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.
- For the quarter ending Q1 2026, Return on Sales rose 1.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2020 full-year result was 0.0%, changed 0.0% from the prior year.
- Return on Sales grew to 0.0% in Q1 2026, from 0.0% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.01% in Q2 2022 to a low of 0.0% in Q1 2025.
- A 3-year average of 0.01% and a median of 0.01% in 2022 frame the typical range for Return on Sales.
- Across the five-year window, Return on Sales changed 0 bps in 2022 and grew 1 bps in 2026, its largest moves.
- Tracing OMER's Return on Sales over 3 years: stood at 0.01% in 2022, then tumbled by 134 bps to 0.0% in 2025, then surged by 231 bps to 0.0% in 2026.
- Business Quant data shows OMER's Return on Sales at 0.0% in Q1 2026, 0.0% in Q1 2025, and 0.01% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Jun 30, 2022 | 0.01% |
| Mar 31, 2022 | 0.01% |
| Dec 31, 2021 | -0.04% |
| Sep 30, 2021 | 0.01% |
| Jun 30, 2021 | 0.01% |
| Mar 31, 2021 | 0.01% |
| Dec 31, 2020 | -0.09% |
| Sep 30, 2020 | -0.01% |
| Jun 30, 2020 | -0.05% |
| Mar 31, 2020 | -0.01% |
| Dec 31, 2019 | -0.03% |
| Sep 30, 2019 | -0.01% |
| Jun 30, 2019 | -0.02% |
| Mar 31, 2019 | -0.01% |
| Dec 31, 2018 | -0.01% |
| Sep 30, 2018 | -0.37% |
| Jun 30, 2018 | -0.66% |
| Mar 31, 2018 | -0.19% |